TR201402220A2 - A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections. - Google Patents

A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections.

Info

Publication number
TR201402220A2
TR201402220A2 TR2014/02220A TR201402220A TR201402220A2 TR 201402220 A2 TR201402220 A2 TR 201402220A2 TR 2014/02220 A TR2014/02220 A TR 2014/02220A TR 201402220 A TR201402220 A TR 201402220A TR 201402220 A2 TR201402220 A2 TR 201402220A2
Authority
TR
Turkey
Prior art keywords
composition
picroretocyte
derivatives
treatment
viral infections
Prior art date
Application number
TR2014/02220A
Other languages
Turkish (tr)
Inventor
Can Alkoçlar Erdal
Original Assignee
Erdal Can Alkoclar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erdal Can Alkoclar filed Critical Erdal Can Alkoclar
Priority to TR2014/02220A priority Critical patent/TR201402220A2/en
Publication of TR201402220A2 publication Critical patent/TR201402220A2/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Buluş, hemaglütinin esteraz baskılamaya yönelik, pikroretosit türevlerini ihtiva eden bir kompozisyon ve bu kompozisyonun viral enfeksiyonların tedavisinde kullanımı ile ilgilidir.The invention relates to a composition comprising picroretocyte derivatives for hemagglutinin esterase suppression and the use of this composition in the treatment of viral infections.

TR2014/02220A 2014-02-25 2014-02-25 A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections. TR201402220A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2014/02220A TR201402220A2 (en) 2014-02-25 2014-02-25 A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2014/02220A TR201402220A2 (en) 2014-02-25 2014-02-25 A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections.

Publications (1)

Publication Number Publication Date
TR201402220A2 true TR201402220A2 (en) 2014-12-22

Family

ID=63833738

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2014/02220A TR201402220A2 (en) 2014-02-25 2014-02-25 A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections.

Country Status (1)

Country Link
TR (1) TR201402220A2 (en)

Similar Documents

Publication Publication Date Title
CY1124663T1 (en) N4-HYDROXYCYTIDINE ANTIBIOTIC DERIVATIVES
PH12017500207A1 (en) Indoles for use in influenza virus infection
BR112018005779A2 (en) htt repressors and uses thereof
PH12016502468B1 (en) Influenza virus vaccines and uses thereof
BR112017005266A2 (en) mk2 inhibitors and their use
WO2015153889A3 (en) Materials and methods for the treatment of latent viral infection
BR112016022658A2 (en) anti-ox40 antibodies and methods of use
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
EP3497209A4 (en) CHIMEAN SMALL VIRUS COMPOSITIONS AND USES THEREOF
EA201692541A1 (en) VACCINES AGAINST FLU VIRUS AND THEIR USE
TR201910057T4 (en) RUBBER COMPOSITIONS
EA201790517A1 (en) METHODS AND COMPOSITIONS FOR INDUCING PROTECTIVE IMMUNITY AGAINST PHILOVIRUS INFECTION
EA201791454A1 (en) DRUG FORMS FOR TRANSDERMAL ADMINISTRATION
DOP2016000336A (en) ISOINDOLIN DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION
BR112017009792A2 (en) anti-pdgf-b antibodies and methods of use
UY36221A (en) ISOINDOLINONE DERIVATIVES
CL2017000151A1 (en) Pyridone derivatives
TR201820050T4 (en) Tetrahydroquinoline derivatives as bromodomain inhibitors.
IL246643A0 (en) Compositions and kits for treating human immunodeficiency virus/accquired immunodeficiency syndrome
TR201819920T4 (en) Ophthalmic compositions for use in the treatment of dry eye syndrome.
EP3122190A4 (en) Compositions and related methods for treating and preventing viral and retroviral infections
TR201402220A2 (en) A composition comprising picroretocyte derivatives which exhibit hemagglutinin esterase-suppressing properties and the use of this composition in the treatment of viral infections.
LT3519050T (en) COMPOSITIONS FOR THE TREATMENT OF OPHTHALMOLOGICAL CONDITIONS
TR201402168A2 (en) A composition comprising components which have been formed for tyrosine kinase suppression and exhibit anti-inflammatory action.